Trelegy Ellipta 200/62.5/25 mcg 30 Doses is a once-daily triple maintenance inhaler combining an inhaled corticosteroid, a long-acting muscarinic antagonist and a long-acting bronchodilator for adult asthma control. Its confirmed composition is Each pre-dispensed dose contains fluticasone furoate 200 micrograms, umeclidinium 62.5 micrograms and vilanterol 25 micrograms.

Adults inhale one dose once daily at the same time. Open the cover only when ready, breathe out away from the inhaler, inhale one long steady deep breath, then rinse the mouth and spit. It is not a rapid-relief inhaler and must not be used for a sudden attack.

Oral thrush, hoarseness, headache, cough, dry mouth, constipation, urinary difficulty or palpitations may occur. Seek urgent care for worsening breathing immediately after inhalation, chest pain, allergic swelling or signs of pneumonia such as fever with increased cough or breathlessness.